Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001398432-21-000040
Filing Date
2021-05-07
Accepted
2021-05-07 09:02:03
Documents
85
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a91298.htm 10-Q 663925
2 NUTRA PHARMA CORP. exh31_1.htm EX-31.1 10195
3 exh32_1.htm EX-32.1 4815
  Complete submission text file 0001398432-21-000040.txt   7298501

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE nphc-20190630_lab.xml EX-101.LAB 623557
5 XBRL DEFINITION FILE nphc-20190630_def.xml EX-101.DEF 406025
6 XBRL PRESENTATION FILE nphc-20190630_pre.xml EX-101.PRE 413986
7 XBRL SCHEMA FILE nphc-20190630.xsd EX-101.SCH 87384
8 XBRL INSTANCE FILE nphc-20190630.xml EX-101.INS 1134769
9 XBRL CALCULATION FILE nphc-20190630_cal.xml EX-101.CAL 45298
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 21900548
SIC: 2833 Medicinal Chemicals & Botanical Products